Answers are grounded in this paper and cite their sources.
Brain injury constitutes a disabling health condition of several etiologies. One of the major causes of brain injury is hypoxia-ischemia. Until recently, pharmacological treatments were solely focused on neurons. In the last decades, glial cells started to be considered as alternative targets for neuroprotection. Novel treatments for hypoxia-ischemia intend to modulate reactive forms of glial cells, and/or potentiate their recovery response. In this review, we summarize these neuroprotective strategies in hypoxia-ischemia and discuss their mechanisms of action.
No takes yet. Share an insight, caveat, or question.
Mucci et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: